AXIM BIOTECHNOLOGIES, INC. (AXIM) › Shareholders' EquityAXIM BIOTECHNOLOGIES, INC. (AXIM) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: $02011: $10.2K2012: -$4.7K2013: -$93.9K2014: -$580.7K2015: -$1.70M2016: -$2.37M2019: -$6.76M2020: $1.57M2021: -$2.34M2022: -$4.83M2023: -$7.66M-$7.66M2010Shareholders' Equity (USD)2023Fiscal YearShareholders' EquityChange YoY2023-$7.66M-58.7%2022-$4.83M-106.4%2021-$2.34M-249.3%2020$1.57M+123.2%2019-$6.76M—2016-$2.37M-39.9%2015-$1.70M-191.9%2014-$580.7K-518.3%2013-$93.9K-1899.1%2012-$4.7K-146.0%2011$10.2K—2010$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share